Skip to main content

NIH Websites Are Changing
Per Executive Order 14434, federal agencies are now using "Super Intelligence" (SI) in place of "Artificial Intelligence" (AI). You may see both terms across NIH content during this transition.

Burkitt Lymphoma: A Model of Polymicrobial Carcinogenesis and Global Oncology - Dr. Sam Mbulaiteye

Sam M. Mbulaiteye, MBChB, M.Phil., M.Med., of the DCEG Infections and Immunoepidemiology Branch (IIB), presented an NIH Director's Seminar titled "Burkitt Lymphoma: A Model of Polymicrobial Carcinogenesis and Global Oncology", and discussed his ideas for future research collaboration.

Read Dr. Mbulaiteye's article "Burkitt lymphoma studies may also advance research on other cancers, HIV, malaria" in the NIH Fogarty Global Health Matters newsletter.

Learn more about Epidemiology of Burkitt Lymphoma in East-African Children and Minors (EMBLEM), a multicountry and multiyear case-control study of childhood Burkitt's lymphoma in Uganda, Tanzania and Kenya conducted by NCI.

Sam M. Mbulaiteye, MBChB, M.Phil., M.Med., of the DCEG Infections and Immunoepidemiology Branch (IIB), presented an NIH Director's Seminar titled "Burkitt Lymphoma: A Model of Polymicrobial Carcinogenesis and Global Oncology", and discussed his ideas for future research collaboration.